Cargando…

Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study)

PURPOSE: Hyperkalemia is a common metabolic complication of chronic kidney disease (CKD) and is associated with several serious adverse events. We aimed to treat/prevent hyperkalemia using the new of potassium-binders, allowing maintained renin-angiotensin-aldosterone system inhibitors (RAASi) treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bjune, Thea, Bøe, Thea Bjerkestrand, Kjellevold, Stig Arne, Heldal, Kristian, Abedini, Sadollah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027611/ https://www.ncbi.nlm.nih.gov/pubmed/36960344 http://dx.doi.org/10.2147/IJNRD.S401623

Ejemplares similares

Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study) [Corrigendum]
Publicado: (2023)

Screening with digital mammography: 2-year experiences from Vestfold County, Norway
por: Vigeland, E, et al.
Publicado: (2006)

Cuff extrusion in peritoneal dialysis: single-centre experience with the cuff-shaving procedure in five patients over a 4-year period
por: Debowski, Jedrzej A., et al.
Publicado: (2017)

A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia
por: Cañas, Alejandro E., et al.
Publicado: (2023)

Selective potassium uptake via biocompatible zeolite–polymer hybrid microbeads as promising binders for hyperkalemia
por: Wang, Zhoujun, et al.
Publicado: (2020)

Treatment outcome of new culture positive pulmonary tuberculosis in Norway
por: Farah, Mohamed Guled, et al.
Publicado: (2005)

Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis
por: Montagnani, Andrea, et al.
Publicado: (2021)

Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders
por: Hida, Yuki, et al.
Publicado: (2023)

Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study
por: Kanda, Eiichiro, et al.
Publicado: (2023)

Patient and health care system delays in the start of tuberculosis treatment in Norway
por: Farah, Mohamed Guled, et al.
Publicado: (2006)

Impact of Plasma Potassium Normalization on Short‐Term Mortality in Patients With Hypertension and Hyperkalemia
por: Krogager, Maria Lukács, et al.
Publicado: (2020)

Piecing Together the Potassium Puzzle: The Weak Association Between Dietary Potassium and Hyperkalemia
por: Joshi, Shivam, et al.
Publicado: (2023)

The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?
por: Batlle, Daniel, et al.
Publicado: (2015)

Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients
por: Plantaz, Milan M. E. A., et al.
Publicado: (2020)

Hyperkalemia caused by rapid red cell transfusion and the potassium absorption filter
por: Imashuku, Yasuhiko, et al.
Publicado: (2017)

Pharmacodynamic effects of the K(+) binder patiromer in a novel chronic hyperkalemia model in spontaneously hypertensive rats
por: Iyer, Sai Prasad N., et al.
Publicado: (2020)

Optimizing Therapies in Heart Failure: The Role of Potassium Binders
por: Scicchitano, Pietro, et al.
Publicado: (2022)

Comment on Montagnani et al. Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis. J. Clin. Med. 2021, 10, 5483
por: Zarzuela, Donna, et al.
Publicado: (2022)

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
por: Bushinsky, David A, et al.
Publicado: (2015)

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice
por: Davidson, James P., et al.
Publicado: (2017)

Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia
por: Israni, Rubeen, et al.
Publicado: (2021)

Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia
por: Huang, Chien-Wei, et al.
Publicado: (2015)

Sodium–calcium exchanger 1 is the key molecule for urinary potassium excretion against acute hyperkalemia
por: Shoda, Wakana, et al.
Publicado: (2020)

The Effect of Patient Factors and Cotreatments on the Magnitude of Potassium Lowering with Insulin–Glucose Treatment in Patients with Hyperkalemia
por: Lim, Andy K. H., et al.
Publicado: (2021)

Hyperkalemia and Rhabdomyolyssis
por: Yasri, Sora, et al.
Publicado: (2015)

Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial( )
por: Packer, Milton
Publicado: (2022)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients — A population-based cohort study
por: Adelborg, Kasper, et al.
Publicado: (2019)

Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
por: Khanagavi, Jagadish, et al.
Publicado: (2014)

Hyperkalemia Among Hospitalized Patients and Association Between Duration of Hyperkalemia and Outcomes
por: Alrashidi, Tahani Nasser, et al.
Publicado: (2020)

A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology
por: Rossignol, Patrick
Publicado: (2019)

Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study
por: Yao, Lan, et al.
Publicado: (2022)

Moderate stepwise restriction of potassium intake to reduce risk of hyperkalemia in chronic kidney disease: A literature review
por: AlSahow, Ali
Publicado: (2023)

Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis
por: Fukushima, Sakae, et al.
Publicado: (2023)

An unusual manifestation of hyperkalemia
por: Belkouch, Ahmed, et al.
Publicado: (2014)

Hyperkalemia and severe rhabdomyolysis
por: Mugmon, Marc
Publicado: (2011)

Hyperkalemia in heart failure
por: Sidhu, Kiran, et al.
Publicado: (2020)

Acute hyperkalemia in adults
por: Emektar, Emine
Publicado: (2023)

Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
por: Amdetsion, Gedion Yilma, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m4nn0he1ru84ksbsg8ih5up48f